Pro-Dex (NASDAQ:PDEX) versus Vycor Medical (OTCMKTS:VYCO) Critical Analysis

Pro-Dex (NASDAQ:PDEXGet Free Report) and Vycor Medical (OTCMKTS:VYCOGet Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation and risk.

Valuation & Earnings

This table compares Pro-Dex and Vycor Medical’s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pro-Dex $46.09 million 1.40 $7.07 million $0.58 32.59
Vycor Medical $1.46 million 2.01 -$70,000.00 N/A N/A

Pro-Dex has higher revenue and earnings than Vycor Medical.

Profitability

This table compares Pro-Dex and Vycor Medical’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Pro-Dex 4.13% 6.50% 4.01%
Vycor Medical -7.49% N/A -10.32%

Institutional and Insider Ownership

15.3% of Pro-Dex shares are held by institutional investors. 42.6% of Pro-Dex shares are held by insiders. Comparatively, 7.0% of Vycor Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of recent recommendations for Pro-Dex and Vycor Medical, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Pro-Dex 0 0 0 0 N/A
Vycor Medical 0 0 0 0 N/A

Volatility & Risk

Pro-Dex has a beta of 0.41, indicating that its stock price is 59% less volatile than the S&P 500. Comparatively, Vycor Medical has a beta of 0.48, indicating that its stock price is 52% less volatile than the S&P 500.

Summary

Pro-Dex beats Vycor Medical on 7 of the 9 factors compared between the two stocks.

About Pro-Dex

(Get Free Report)

Pro-Dex, Inc. designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets. It also provides engineering, quality, and regulatory consulting services; and manufactures and sells rotary air motors to various industries. The company's products are used in hospitals, medical engineering labs, scientific research facilities, and high-tech manufacturing operations. Pro-Dex, Inc. was founded in 1978 and is headquartered in Irvine, California.

About Vycor Medical

(Get Free Report)

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.

Receive News & Ratings for Pro-Dex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pro-Dex and related companies with MarketBeat.com's FREE daily email newsletter.